Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Novanta (NOVT) Research & Development: 2009-2025

Historic Research & Development for Novanta (NOVT) over the last 17 years, with Sep 2025 value amounting to $24.1 million.

  • Novanta's Research & Development rose 3.60% to $24.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $97.9 million, marking a year-over-year increase of 4.50%. This contributed to the annual value of $95.5 million for FY2024, which is 4.18% up from last year.
  • As of Q3 2025, Novanta's Research & Development stood at $24.1 million, which was down 4.74% from $25.3 million recorded in Q2 2025.
  • Novanta's 5-year Research & Development high stood at $25.3 million for Q2 2025, and its period low was $17.0 million during Q3 2021.
  • Its 3-year average for Research & Development is $23.6 million, with a median of $23.4 million in 2023.
  • Its Research & Development has fluctuated over the past 5 years, first increased by 27.33% in 2022, then fell by 0.03% in 2025.
  • Novanta's Research & Development (Quarterly) stood at $19.4 million in 2021, then climbed by 12.80% to $21.9 million in 2022, then increased by 7.07% to $23.5 million in 2023, then rose by 7.82% to $25.3 million in 2024, then rose by 3.60% to $24.1 million in 2025.
  • Its Research & Development stands at $24.1 million for Q3 2025, versus $25.3 million for Q2 2025 and $23.2 million for Q1 2025.